National Health Investors (WX6) Stock Statistics & Valuation Metrics

National Health Investors has a market cap or net worth of CHF2.69B. The enterprise value is CHF4.96B.

National Health Investors has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

National Health Investors’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.97%.

The current PE Ratio of National Health Investors is 19.1. National Health Investors’s PEG ratio is -7.19.

In the last 12 months, National Health Investors had revenue of 378.53M and earned 142.18M in profits. Earnings per share was 3.03.

In the last 12 months, operating cash flow was 250.87M and capital expenditures -15.16M, giving a free cash flow of 235.71M billion.

National Health Investors pays an annual dividend of ―, resulting in a dividend yield of ―

National Health Investors upcoming earnings date is Nov 9, 2026, Before Open (Confirmed).

National Health Investors as a current ratio of 2.48, with Debt / Equity ratio of 81.74%

In the past 12 months, National Health Investors has paid 0.00 in taxes.

National Health Investors EV to EBITDA ratio is 16.75, with an EV/FCF ratio of 21.45.

National Health Investors has CHF30.39M in cash and marketable securities with CHF1.28B in debt, giving a net cash position of -CHF1.25B billion.

Gross margin is 56.25%, with operating margin of 51.47%, and net profit margin of 37.56%.

The average price target for National Health Investors is CHF68.16, which is 11.43% higher than the current price. The consensus rating is Strong Buy